LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called CRPA1A2, which helps the body's immune cells attack cancer cells. It is for people with certain advanced solid tumors (like lung, esophagus, head and neck, or liver cancer) that have not responded to other treatments. The study will …
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aims to fix Immunotherapy's blood problems in lung cancer
Disease control Not yet recruitingThis phase 2 trial tests the drug golidocitinib in 16 people with advanced lung cancer who have severe blood problems caused by immunotherapy. The goal is to see if the drug can safely improve blood counts and reduce symptoms. Participants take the drug until their blood levels r…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could your own immune cells fight advanced cancer? new trial aims to find out
Disease control Not yet recruitingThis study tests a therapy that takes a patient's own immune cells, grows and strengthens them in a lab, and then gives them back to fight cancer. It is for people with advanced lung, liver, colorectal, or breast cancer that has spread. The goal is to see if this approach is safe…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a quick extra flush prevent lung cancer staging errors?
Knowledge-focused Not yet recruitingThis study looks at whether an extra cleaning step during a common lung cancer staging procedure (EBUS) can reduce contamination of tissue samples. Researchers will collect samples from 204 adults with suspected lung cancer. The goal is to see if better cleaning leads to more acc…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: University of Mississippi Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC